Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 411 to 420

Entecavir Apotex entecavir (as monohydrate) 0.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
Voriconazole APOTEX voriconazole 200mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
Voriconazole APOTEX voriconazole 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
Oxytocin APOTEX oxytocin 5 IU/1 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
Entecavir Apotex entecavir (as monohydrate) 1mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART DULOXETINE duloxetine (as hydrochloride) 30 mg enteric capsule blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART DULOXETINE duloxetine (as hydrochloride) 60 mg enteric capsule blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
Terry White Chemists ROSUVASTATIN 10 mg rosuvastatin calcium 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
Chemmart ROSUVASTATIN 40 mg rosuvastatin calcium 40 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
Chemmart ROSUVASTATIN 20 mg rosuvastatin calcium 20 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 38
Page 39
Page 40
Page 41
Current page 42
Page 43
Page 44
Page 45
Page 46
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.